Shree Ganesh Bio

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE051N01026
  • NSEID:
  • BSEID: 539470
INR
0.53
-0.01 (-1.85%)
BSENSE

Aug 10

BSE+NSE Vol: 5.91 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 999946,
    "name": "Shree Ganesh Bio",
    "stock_name": "Shree Ganesh Bio",
    "full_name": "Shree Ganesh Biotech India Ltd",
    "name_url": "stocks-analysis/shree-ganesh-bio",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.53",
    "chg": -0.01,
    "chgp": "-1.85%",
    "dir": -1,
    "prev_price": "0.54",
    "mcapval": "21.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539470,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 61,
    "indexname": "India SENSEX",
    "isin": "INE051N01026",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "5.91 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/shree-ganesh-bio-999946-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "999946",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/shree-ganesh-biotech-india-999946"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th August 2026.",
      "datetime": "04-Aug-2026",
      "details": "Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Tuesday 4th August2026. at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June 2026. The board meeting commented at 03:50 PM and concluded at 04:10 PM Please take the above intimation in your records. Thanking You.",
      "source": "BSE"
    },
    {
      "caption": "Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
      "datetime": "04-Aug-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015",
      "datetime": "04-Aug-2026",
      "details": "PFA",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Biotech India Ltd has announced <strong>1:10</strong> stock split, ex-date: 10 Feb 22",
          "dt": "2022-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Biotech India Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 27 Apr 22",
          "dt": "2022-04-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th August 2026.

04-Aug-2026 | Source : BSE

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Tuesday 4th August2026. at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June 2026. The board meeting commented at 03:50 PM and concluded at 04:10 PM Please take the above intimation in your records. Thanking You.

Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)

04-Aug-2026 | Source : BSE

PFA

Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015

04-Aug-2026 | Source : BSE

PFA

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Shree Ganesh Biotech India Ltd has announced 1:10 stock split, ex-date: 10 Feb 22

stock-summary
BONUS

Shree Ganesh Biotech India Ltd has announced 1:1 bonus issue, ex-date: 27 Apr 22

stock-summary
RIGHTS

No Rights history available